The 1st Participant in A New CHECK-NIRS Clinical Study is Enrolled!
Stefan Hof, Clinical scientist and anesthesiologist at University Hospital of Düsseldorf, shared on LinkedIn:
”Together with our medical doctoral candidate Annalena Müllers we enrolled the first participant in our new clinical study – the CHECK-NIRS study.
In this project, we will systematically investigate external and behavioural factors influencing NIRS-based 2D-imaging.
This marks an important first step in translating our predominantly experimental findings into clinical application, with the goal of gaining deeper insights into tissue oxygenation in humans.
I am particularly looking forward to collaborating with Patricia Wischmann from the Department of Cardiology, Pneumology and Angiology at University Hospital Düsseldorf, Kalman Bodis from the Department of Endocrinology and Diabetology at University Hospital Düsseldorf and Katharina Post from inovex GmbH.
A big thank you to everyone involved for your dedication and teamwork!”
Stay updated with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering